|
|
||||||||
|

FIGURE 4. Cross section of CAP stained with antihuman nuclear Ki-67 antibody MIB-1 and lightly counterstained with hematoxylin. Amount of Ki-67positive tumor cells is approximately 2% in this cross section. Left upper part of figure shows newly formed reactive lymph node with lightly positive Ki-67 immunostaining. (x200)
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |